Ah Biotech Incomplete

3998 Words16 Pages
AH Biotech A Case Analysis S110237 & S110214 FACTS OF THE CASE * AH Biotech, a Bound Brook, New Jersey-based company * Dr. Abraham Hassan, Egyptian-born, psychiatrist-turned-entrepreneur, founder and CEO of the company * Recently developed a drug to address long-term relief from panic attacks, needing large-scale clinical trials – the company’s first product if it gained FDA approval * David Berger, Head of Research and Development, suggested Albania as the location to conduct the trials because it would be quicker, easier, and a lot cheaper than doing trials in the States, possibly realizing at least 25 percent savings * Doing trials in United States would cost considerable time and money advertising for patients, and looking for physicians to serve as clinical trial investigators * Doing trials in Albania, one of the poorest European countries, physicians would be very willing to take part because they could earn much better pay from a U.S. company than from actually practicing medicine; patients saw signing up for the test as their best chance for receiving any treatment at all, especially from cutting-edge Western medicine * U.S. test subjects would have insurance to cover most of their prescriptions to continue with the medication after the trials * If tests were done in Albania, the company would have to cut off the treatment when the study is over, because it wouldn’t be feasible to market the drug in a poor country like Albania * Investors and employees are hoping for the company’s first marketable drug STATEMENT OF THE PROBLEM Which location would Dr. Abraham Hassan choose that would be of best interest to the organization’s stakeholders? KEY OBJECTIVES * Determine the best location to do the trials * Establish a good entry to the market * Formulate a business strategy that would enhance
Open Document